TRACON Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate Update
SAN DIEGO, Aug. 08, 2017 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age‐related macular degeneration …